Trial
NCT00868998
GTX Regimen for Biliary Cancers
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Biliary Cancer
Intervention
Gemcitabine, docetaxel, and capecitabine
Why stopped
Poor patient accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-23